apposters.com

MOSH Secures $13M to Fuel Brain Health Revolution and National Expansion

May 13, 2026, 9:37 pm
Mosh
Mosh
ConsumerFoodTechHealthTechNutritionWellness
Location: United States
Total raised: $13M
MOSH, a trailblazing brain health nutrition brand, has successfully secured $13 million in Series A funding. This substantial investment will accelerate aggressive national retail expansion, including a major Target rollout. The capital also supports innovative new product development, notably a high-protein bar formulated for cognitive support. Co-founded by Maria Shriver and Patrick Schwarzenegger, MOSH pioneers functional foods for optimal cognitive vitality. A portion of these funds will advance critical research into gut biomarkers associated with cognitive decline and Alzheimer's disease. The company anticipates tripling its retail footprint this year, reinforcing its market leadership and profound commitment to brain wellness across the nation.

MOSH, a prominent name in functional nutrition, announces a significant financial milestone. The company closed a $13 million Series A financing round. This investment marks a pivotal moment for the rapidly growing brain health brand.

Main Street Advisors spearheaded the funding initiative. Key participants included Great Circle Ventures, Rogers Healy and Morrison Seger, PCG, and Tonic Ventures. This collective backing signals strong market confidence in MOSH's mission and growth trajectory. The capital infusion is earmarked for robust strategic expansion.

MOSH focuses on the intersection of physical fitness and cognitive health. It produces functional nutrition products designed for brain vitality. These products offer proactive care for long-term cognitive well-being. The brand addresses a critical, underserved area in consumer health.

Co-founded by Maria Shriver and Patrick Schwarzenegger, MOSH blends celebrity influence with a genuine health mission. Shriver brings personal advocacy for Alzheimer's awareness and women's brain health. Schwarzenegger represents a generation focused on foundational wellness habits. Their combined vision drives the brand forward.

MOSH's core offerings are protein bars. These bars integrate essential protein with powerful nootropics and adaptogens. Each ingredient targets specific aspects of cognitive function. They aim to support focus, memory, and overall brain resilience.

Key ingredients define MOSH's scientific approach. Cognizin Citicoline, a clinically studied compound, supports mental energy and focus. MOSH proudly claims its bars are the first protein bars to feature this ingredient. Lion's Mane, a functional mushroom, is known for its potential nerve health benefits. Ashwagandha, a revered adaptogen, helps manage stress and cortisol balance. Omega-3s, sourced from flaxseed, provide crucial fatty acids. Vitamins B12 and D3 are included for comprehensive neurological and immune support. This blend highlights a commitment to holistic brain wellness.

A primary use of the Series A funds involves national retail expansion. MOSH plans an upcoming nationwide rollout at Target in May 2026. This move will significantly broaden its consumer reach. The brand currently boasts a presence in over 2,000 retail locations across the United States. Its current partners include Sprouts Farmers Market, Albertsons, Kroger, and HEB. MOSH projects its retail business to triple in 2026. Increased distribution across major national retailers will drive this substantial growth.

New product development represents another strategic priority. MOSH will launch "MOSH High Protein," an innovative protein bar. This new offering will pack 20 grams of protein. It will also include creatine, known for its cognitive and physical benefits. The bar features the proprietary MOSH Signature Brain Blend. This launch positions MOSH at the forefront of combining high protein with advanced brain health ingredients.

Research initiatives also receive a significant portion of the funding. MOSH is deeply committed to advancing brain health science. The company plans to fund a third research grant in 2026. This grant will focus on gut biomarkers. It specifically investigates their association with cognitive decline and Alzheimer's disease. This research underscores MOSH's dedication to scientific discovery.

MOSH partners with the Women’s Alzheimer’s Movement at Cleveland Clinic. This collaboration strengthens its philanthropic efforts. A portion of proceeds from every MOSH bar sold funds Alzheimer's research and women’s brain health initiatives. The company has already raised over $400,000 for these causes. It has funded three research grants to date. This commitment aligns business growth with social impact.

Operational scaling is crucial for sustaining rapid expansion. The investment supports growth across several key areas. These include marketing, sales, and supply chain infrastructure. Building a robust operational backbone ensures efficient product delivery and brand visibility. This scaling will solidify MOSH's position as a category leader.

The functional nutrition market is experiencing explosive growth. Consumers increasingly seek products offering targeted health benefits. Brain health, in particular, has emerged as a major focus. MOSH expertly taps into this evolving consumer demand. Its focus on proactive cognitive care resonates with a broad demographic.

MOSH is not just selling protein bars. It is building a platform for brain health awareness and education. The brand's rapid growth reflects a societal shift. People prioritize long-term wellness and cognitive vitality. MOSH provides accessible, delicious solutions for everyday brain nourishment.

This $13 million Series A round empowers MOSH to accelerate its mission. The investment facilitates broader product accessibility. It fuels continued innovation. It supports critical scientific research. MOSH stands poised to redefine the brain health nutrition landscape. Its impact extends beyond individual consumers to the broader fight against cognitive decline. The future looks bright for this brain-focused pioneer.